Accelerating ADC Process Development

The rapid advancement of ADCs put the fine balance between speed to IND and robust process development to the test, especially when scaling up and transferring production.

In this engaging Bioprocess Online Live panel, leading ADC developers shared the innovative strategies they used to mitigate manufacturing-scale risks. They also revealed how automation and artificial intelligence were beginning to transform their processes.

Catch this insightful, on-demand discussion featuring Dr. Monika Lamba Saini (ADC Therapeutics), Dr. Léo Marx (Debiopharm), and Dr. Philipp Spycher (Araris Biotech).

Available on-demand thanks to the support of Thermo Fisher Scientific.